Deals review
- Deals review
- Deal details
Xcellerex Signs Memorandum of Understanding with SK Chemicals to Commercialize SK-Developed Vaccines with FlexFactory® Platform
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Related deals
Roswell Park and Empire Genomics Agree on Memorandum of Understanding
Akorn, Inc. Enters into Exclusive Vaccine Partnership with Serum Institute of India, Ltd.
Biocon signs Memorandum of Understanding with Deakin University, Australia
Panacea Biotec signs agreement with Family Vaccines to supply combination vaccines in Philippines
Helix signs memorandum of intent with MAXX Bioscience
Calypte Enters Into Memorandum of Understanding with Beijing Tiantan Biological Products
Solvay signs agreement aiming at acquisition of Fournier Pharma
GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
More deals
Latest deals
- Biovator and BASF sign technology development agreement
- Agfa HealthCare signs four-year agreement with Chinese partners for distribution of radiography solutions, potentially worth 500 million US dollar
- Omnicare Announces Acquisition of Continuing Care Rx
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
Most viewed deals
- Recommended acquisition of Acambis plc ("Acambis") by Sanofi Pasteur Holding ("Sanofi Pasteur") by way of scheme of arrangement Posting of Scheme Document
- Omnicare Announces Acquisition of Continuing Care Rx
- Bayer CropScience and Janssen PMP conclude research agreement:
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- Biovator and BASF sign technology development agreement
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us